Australian company Noxopharm (ASX:NOX) has reported positive end-of-study data from its DARRT-1 Phase 1b trial of Veyonda. …
Latest Video
New Stories
-
Gilead announces first grants under new HIV program
January 29, 2020 - - Latest News -
MA: Would be 'surprised' by any approach for savings
January 29, 2020 - - Latest News -
Greg Hunt to host the first meeting of NMP review stakeholder group
January 29, 2020 - - Latest News -
MSAC: Advises government to 'utilise' competition on CAR-T
January 29, 2020 - - Latest News -
When was the last time a health minister did that?
January 28, 2020 - - Latest News -
Recognition for Department of Health official
January 28, 2020 - - Latest News -
More confirmed speakers for BioPharmaDispatch 2020
January 28, 2020 - - Latest News